Annual Meeting Symposium III: DVT Prophylaxis, So Much New Data, What Am I Supposed To Do?

Friday, October 20, 2023

8:00 AM – 9:00 AM PST

Location: 4B

Moderator(s)

Reza Firoozabadi, MD, MA

Associate Professor of Orthopedics and Sports Medicine
University of Washington, Harborview Medical Center
Seattle, Washington, United States

Disclosure(s): Depuy-Synthes: Consultant (Ongoing); Smith & Nephew: Consultant (Ongoing)

Faculty(s)

Reza Firoozabadi, MD, MA

Associate Professor of Orthopedics and Sports Medicine
University of Washington, Harborview Medical Center
Seattle, Washington, United States

Disclosure(s): Depuy-Synthes: Consultant (Ongoing); Smith & Nephew: Consultant (Ongoing)
Prism Schneider, MD, PhD (she/her/hers)

Associate Professor and Orthopaedic Trauma Surgeon
University of Calgary
Calgary, Alberta, Canada

Disclosure(s): Johnson and Johnson: Grant or Research Support, or I am listed as the PI (Ongoing); Smith and Nephew: Grant or Research Support, or I am listed as the PI (Ongoing)
Malcolm R. DeBaun, MD

Director of Orthopaedic Trauma
Duke University School of Medicine
Duke University Hospital
Durham, North Carolina, United States

Disclosure(s): Azra Care: ownership/equity (Ongoing); Metalogix: Consultant (Ongoing); Next Science: Consultant (Ongoing), Grant or Research Support, or I am listed as the PI (Ongoing); NSite Medical: ownership/equity (Ongoing); Resolute: Consultant (Ongoing), ownership/equity (Ongoing); Shukla: Consultant (Ongoing), Other Financial or Material Support (Ongoing); SI Bone: Consultant (Ongoing); Synthes: Consultant (Ongoing), Grant or Research Support, or I am listed as the PI (Ongoing)
John A. Scolaro, MD, MA (he/him/his)

Associate Professor
University of California, Irvine
Orange, California, United States

Disclosure(s): No financial relationships to disclose
RO

Robert V. O'Toole, MD

Professor, Orthopaedic Surgery
University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center
Baltimore, Maryland, United States

Disclosure(s): imagen: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); lincotek: Other Financial or Material Support (Ongoing); stryker: Consultant (Ongoing)
Yelena Bogdan, MD

Orthopaedic Trauma Surgeon
Bronx, New York, United States

Disclosure(s): Smith and Nephew: Consultant (Ongoing)

DVT prophylaxis has always been an important topic in the field of orthopaedic trauma. A number of high quality studies have come out over the past three years that pertain to this topic and no general consensus has yet to be made in a number of areas. This has resulted in gaps and in certain cases potential changes to the standard of care that need to be addressed. The purpose of this symposia is to address some of these gaps and to educate the membership on what is most appropriate based on the available high quality data. Five areas of discussion that will be targeted by this diverse group of presenters will be; 1)The use of Aspirin versus Enoxaparin Sodium for VTE prevention, 2)Does new data support the additional use of non-pharmalogic/mechanical (compression stockings/SCD's) to prevent DVT's 3)Should we be using thrombelastography to identify hypercoagulability in patients with orthopeadic trauma related injuries, 4)What is the most appropriate management for patients with different VTE events (proximal versus distal clots). Do all PE's need full anticoagulation? 5)What are newer pharmalogic agents that are being used for DVT prophylaxis? Does any of the data support using them?

Learning Objectives:

At the completion of this activity, participants will be able to:

Determine what is the most appropriate pharmacologic agent to use to prevent a venous thromboembolic event in the orthopaedic trauma patient.
Assess different non-pharmacologic /mechanical forms of prophylaxis and to determine if they are indicated to prevent a venous thromboembolic event in the orthopaedic trauma patient.
Determine the role of thrombelastography and newer pharmacologic agents in the prevention of venous thromboembolic events.